June 12, 2023 by Chain Drug Review
Alpro Pharmacy, Malaysian pharmacy harnesses Zebra technology
June 13, 2022, Technology

KUALA LUMPUR, Malaysia — Zebra Technologies Corp. announced earlier this year that Malaysia’s largest prescription pharmacy chain, Alpro Pharmacy, has introduced Zebra’s mobile computing and RFID solutions to digitalize its manual inventory management system to advance with its fast-growing business. The first stage of digitalization was to equip Alpro Pharmacy’s front-line workers with Zebra’s TC21 touch
June 15, 2022 by Chain Drug Review
diabetes roundtable
June 13, 2022, Leading Headlines, Pharmacy

While the pandemic may be waning, the newly gained prominence of pharmacists has positioned them to take a more active role in diabetes management. In this virtual roundtable, retailers and suppliers discuss new approaches to helping people manage a condition affecting more than 37 million Americans, and the most exciting new technologies that can support
June 14, 2022 by Chain Drug Review
Chip Davis is the president and CEO of the Healthcare Distribution Alliance
June 13, 2022, Leading Headlines, Supplier News

Chester (Chip) Davis Jr., president and chief executive officer of the Healthcare Distribution Alliance, recently answered questions from Chain Drug Review about drug wholesaling in the aftermath of the pandemic and other industry issues. Following is an edited transcript of that Q&A. CDR: What are the key takeaways from distributors’ resilience during the pandemic, and
June 14, 2022 by Bill Schiffner
Sharon Sternheim, Zitomer
June 13, 2022, Leading Headlines, Retail News

NEW YORK — They say it’s all about the experience, and New York City-based Zitomer offers a one-stop shopping experience quite unlike any other drug store out there. The vast assortment of high-end beauty and personal care products, jewelry, toys and apparel gives it features that rival a department store, but it also offers a
June 13, 2022 by Steven Anderson
NACDS president and chief executive officer Steven Anderson, NACDS RxIMPACT
June 13, 2022, Leading Headlines, Opinion

With primaries well under way and less than six months remaining until Election Day, the time is now for the people of pharmacy to make their voices heard. This year, the 2022 Congressional elections have unique dynamics — with tight margins in the Senate and House of Representatives, a significant number of retirements and individuals
June 13, 2022 by Jeffrey Woldt
CVS, Michelle Peluso
June 13, 2022, Opinion

A recent study by McKinsey & Co. examines the imperative for technological transformation in retailing. Citing a range of factors that are currently reshaping the industry, the report asserts that a strong foundation in digital technology is essential for driving growth and facilitating the emergence of new business models. Michelle Peluso, who joined CVS Health
June 13, 2022 by David Pinto
2022 NACDS Annual
June 13, 2022, Opinion

Here, somewhat belatedly, are some final thoughts about the National Association of Chain Drug Stores’ Annual Meeting, held in late April in Palm Beach, Fla. In terms of overall impressions, it must be said at the outset that this much-anticipated event was all its strongest supporters had hoped for — and one which even its
June 13, 2022 by Bob Kwait
2022 NACDS Annual
June 13, 2022, Opinion, Uncategorized

As I evaluate the Annual Meeting of late April, I must first compliment the National Association of Chain Drug Stores for an outstanding job of organizing a successful conference. It was an exceptional meeting that came together with participation from both new and current members. It’s extremely difficult to plan a meeting of this scale,
June 13, 2022 by Harini Bupathi and Dae Lee
pharmacy
June 13, 2022, Opinion

Pharmacy benefit managers (PBMs) regularly conduct audits on pharmacies to review their performance in relation to the PBM’s terms and conditions. There are several different types of compliance audits that PBMs may initiate, such as desktop, on-site, invoice or virtual. In order to be prepared for audits, pharmacies are encouraged to proactively undertake efforts to
April 26, 2022 by John O'Brien
John O’Brien is president and chief executive officer of the National Pharmaceutical Council.
April 25, 2022, June 13, 2022, Opinion

The broad array of medicines available, from the newest innovation to the most tried-and-true generic, saves and improves the lives of patients everywhere, providing tremendous value. But the ecosystem in the United States that results in innovative medications being discovered and ultimately dispensed to patients at the pharmacy counter is hampered by an opaque pricing